为什么诊断重度抑郁症具有挑战性？
Why is Diagnosing MDD Challenging?
作者信息
Liu Xiaohua, Jiang Kaida
机构信息
Division of Mood Disorders, Department of Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China.
出版信息
Shanghai Arch Psychiatry. 2016 Dec 25;28(6):343-345. doi: 10.11919/j.issn.1002-0829.216073.
Abstract
Depression is highly prevalent and one of the major contributors to disability worldwide. However, one of the findings from the DSM-5 field trials was that inter-rater reliability for diagnosing major depressive disorder was very poor. Why is diagnosing MDD so challenging? This article attempts to explain why undefined pathogenesis and complicated phenotypes complicate the diagnosis of MDD. However, further biomarker and translational research is still necessary to help clinicians screen and diagnose depression in the future rather than relying solely on current subjective diagnostic criteria.
摘要
抑郁症极为普遍，是全球致残的主要原因之一。然而，《精神疾病诊断与统计手册》第五版（DSM - 5）现场试验的结果之一是，诊断重度抑郁症的评定者间信度非常低。为什么诊断重度抑郁症如此具有挑战性？本文试图解释未明确的发病机制和复杂的表型如何使重度抑郁症的诊断变得复杂。然而，未来仍需要进一步的生物标志物和转化研究，以帮助临床医生筛查和诊断抑郁症，而不是仅仅依赖当前主观的诊断标准。
相似文献
1
Why is Diagnosing MDD Challenging?为什么诊断重度抑郁症具有挑战性？
Shanghai Arch Psychiatry. 2016 Dec 25;28(6):343-345. doi: 10.11919/j.issn.1002-0829.216073.
2
Psychiatrists' and nonpsychiatrist physicians' reported use of the DSM-IV criteria for major depressive disorder.精神科医生和非精神科医生报告了使用 DSM-IV 重度抑郁症标准的情况。
J Clin Psychiatry. 2010 Mar;71(3):235-8. doi: 10.4088/JCP.08m04940blu. Epub 2010 Jan 26.
3
Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive Disorder.有进展吗？重度抑郁症生物标志物候选物的选择概述。
Front Psychiatry. 2016 Apr 25;7:72. doi: 10.3389/fpsyt.2016.00072. eCollection 2016.
4
[Bipolar Disorder and Major Depressive Disorder in DSM-5: How to Manage in Clinical and Research Fields].[《精神疾病诊断与统计手册》第5版中的双相情感障碍和重度抑郁症：如何在临床和研究领域进行管理]
Seishin Shinkeigaku Zasshi. 2015;117(10):837-43.
5
What is the best screening test for depression in chronic spinal pain patients?慢性脊柱疼痛患者抑郁症的最佳筛查测试是什么？
Spine J. 2014 Jul 1;14(7):1175-82. doi: 10.1016/j.spinee.2013.10.037. Epub 2013 Nov 10.
6
Diagnosing major depressive disorder V: applying the DSM-IV exclusion criteria in clinical practice.诊断重度抑郁症V：在临床实践中应用《精神疾病诊断与统计手册》第四版排除标准
J Nerv Ment Dis. 2006 Jul;194(7):530-3. doi: 10.1097/01.nmd.0000224882.67660.3d.
7
Diagnosing major depressive disorder IV: relationship between number of symptoms and the diagnosis of disorder.重度抑郁症的诊断IV：症状数量与疾病诊断之间的关系
J Nerv Ment Dis. 2006 Jun;194(6):450-3. doi: 10.1097/01.nmd.0000221425.04436.46.
8
Diagnostic accuracy of serum brain derived neurotrophic factor concentration in antidepressant naïve patients with first major depression episode.抗抑郁药初发抑郁症患者血清脑源性神经营养因子浓度对诊断的准确性。
J Psychiatr Res. 2013 Feb;47(2):162-7. doi: 10.1016/j.jpsychires.2012.09.017. Epub 2012 Oct 23.
9
Should criteria be specified for depressive disorder not otherwise specified?是否应为未特定的抑郁障碍指定标准？
J Affect Disord. 2013 May;147(1-3):118-22. doi: 10.1016/j.jad.2012.10.020. Epub 2012 Nov 17.
10
Suggested Biomarkers for Major Depressive Disorder.重度抑郁症的潜在生物标志物
Noro Psikiyatr Ars. 2018 May 28;55(3):280-290. doi: 10.5152/npa.2017.19482. eCollection 2018 Sep.
引用本文的文献
1
Explainable Machine Learning in the Prediction of Depression.可解释机器学习在抑郁症预测中的应用
Diagnostics (Basel). 2025 Jun 2;15(11):1412. doi: 10.3390/diagnostics15111412.
2
Acceptability, Usability, and Insights Into Cybersickness Levels of a Novel Virtual Reality Environment for the Evaluation of Depressive Symptoms: Exploratory Observational Study.一种用于评估抑郁症状的新型虚拟现实环境的可接受性、可用性及晕动症水平洞察：探索性观察研究
JMIR Form Res. 2025 Apr 16;9:e68132. doi: 10.2196/68132.
3
Elevated Serum IL-2 Levels are Associated With Major Depressive Disorder: A Case-Control Study.血清白细胞介素-2水平升高与重度抑郁症相关：一项病例对照研究。
Clin Pathol. 2023 Jun 15;16:2632010X231180797. doi: 10.1177/2632010X231180797. eCollection 2023 Jan-Dec.
4
Assessment of current clinical practices for major depression in Japan using a web-based questionnaire.使用基于网络的调查问卷评估日本目前针对重度抑郁症的临床实践。
Neuropsychiatr Dis Treat. 2019 Oct 1;15:2821-2832. doi: 10.2147/NDT.S217098. eCollection 2019.
本文引用的文献
1
The Current Situation on Major Depressive Disorder in China: Research on Mechanisms and Clinical Practice.中国重度抑郁症的现状：机制研究与临床实践
Neurosci Bull. 2016 Aug;32(4):389-97. doi: 10.1007/s12264-016-0037-6. Epub 2016 May 30.
2
Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive Disorder.有进展吗？重度抑郁症生物标志物候选物的选择概述。
Front Psychiatry. 2016 Apr 25;7:72. doi: 10.3389/fpsyt.2016.00072. eCollection 2016.
3
Should major depressive disorder with mixed features be classified as a bipolar disorder?具有混合特征的重度抑郁症是否应归类为双相情感障碍？
Shanghai Arch Psychiatry. 2014 Oct;26(5):294-6. doi: 10.11919/j.issn.1002-0829.214146.
4
Mental health: a world of depression.心理健康：抑郁的世界。
Nature. 2014 Nov 13;515(7526):181. doi: 10.1038/515180a.
5
Gene-environment interactions in common mental disorders: an update and strategy for a genome-wide search.常见精神障碍的基因-环境相互作用：全基因组搜索的更新和策略。
Soc Psychiatry Psychiatr Epidemiol. 2014 Jan;49(1):3-14. doi: 10.1007/s00127-013-0801-0. Epub 2013 Dec 10.
6
Major depressive disorder in DSM-5: implications for clinical practice and research of changes from DSM-IV.DSM-5 中的重度抑郁症：DSM-IV 变化对临床实践和研究的影响。
Depress Anxiety. 2014 Jun;31(6):459-71. doi: 10.1002/da.22217. Epub 2013 Nov 22.
7
Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010.按国家、性别、年龄和年份划分的抑郁障碍负担：来自 2010 年全球疾病负担研究的发现。
PLoS Med. 2013 Nov;10(11):e1001547. doi: 10.1371/journal.pmed.1001547. Epub 2013 Nov 5.
8
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.归因于精神和物质使用障碍的疾病全球负担：来自 2010 年全球疾病负担研究的结果。
Lancet. 2013 Nov 9;382(9904):1575-86. doi: 10.1016/S0140-6736(13)61611-6. Epub 2013 Aug 29.
9
DSM-5 field trials in the United States and Canada, Part I: study design, sampling strategy, implementation, and analytic approaches.DSM-5 现场试验：美国和加拿大第一部分：研究设计、抽样策略、实施和分析方法。
Am J Psychiatry. 2013 Jan;170(1):43-58. doi: 10.1176/appi.ajp.2012.12070998.
10
DSM-5 field trials in the United States and Canada, Part II: test-retest reliability of selected categorical diagnoses.《精神障碍诊断与统计手册》第五版（DSM-5）在美国和加拿大的现场测试，第二部分：部分类别诊断的重测信度。
Am J Psychiatry. 2013 Jan;170(1):59-70. doi: 10.1176/appi.ajp.2012.12070999.
Zotero 插件